- Home
- SCLX vs NDLS Comparison
SCLX vs NDLS Comparison
Compare SCLX & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCLX
- NDLS
- Stock Information
- Founded
- SCLX 2011
- NDLS 1995
- Country
- SCLX United States
- NDLS United States
- Employees
- SCLX N/A
- NDLS N/A
- Industry
- SCLX Biotechnology: Pharmaceutical Preparations
- NDLS Restaurants
- Sector
- SCLX Health Care
- NDLS Consumer Discretionary
- Exchange
- SCLX Nasdaq
- NDLS Nasdaq
- Market Cap
- SCLX 35.7M
- NDLS 32.9M
- IPO Year
- SCLX N/A
- NDLS 2013
- Fundamental
- Price
- SCLX $18.87
- NDLS $0.73
- Analyst Decision
- SCLX Strong Buy
- NDLS Buy
- Analyst Count
- SCLX 3
- NDLS 2
- Target Price
- SCLX $367.50
- NDLS $3.00
- AVG Volume (30 Days)
- SCLX 324.6K
- NDLS 214.6K
- Earning Date
- SCLX 08-13-2025
- NDLS 08-13-2025
- Dividend Yield
- SCLX N/A
- NDLS N/A
- EPS Growth
- SCLX N/A
- NDLS N/A
- EPS
- SCLX N/A
- NDLS N/A
- Revenue
- SCLX $44,236,000.00
- NDLS $494,752,000.00
- Revenue This Year
- SCLX $89.26
- NDLS $1.19
- Revenue Next Year
- SCLX $203.95
- NDLS N/A
- P/E Ratio
- SCLX N/A
- NDLS N/A
- Revenue Growth
- SCLX N/A
- NDLS N/A
- 52 Week Low
- SCLX $3.60
- NDLS $0.55
- 52 Week High
- SCLX $45.15
- NDLS $1.74
- Technical
- Relative Strength Index (RSI)
- SCLX 63.34
- NDLS 41.94
- Support Level
- SCLX $15.61
- NDLS $0.70
- Resistance Level
- SCLX $22.01
- NDLS $1.11
- Average True Range (ATR)
- SCLX 2.21
- NDLS 0.08
- MACD
- SCLX -0.14
- NDLS -0.03
- Stochastic Oscillator
- SCLX 62.35
- NDLS 12.73
About SCLX Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for relieving pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.